BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 27489136)

  • 1. Multifunctional T Cell Response to DosR and Rpf Antigens Is Associated with Protection in Long-Term Mycobacterium tuberculosis-Infected Individuals in Colombia.
    Arroyo L; Rojas M; Franken KL; Ottenhoff TH; Barrera LF
    Clin Vaccine Immunol; 2016 Oct; 23(10):813-824. PubMed ID: 27489136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell responses to DosR and Rpf proteins in actively and latently infected individuals from Colombia.
    Riaño F; Arroyo L; París S; Rojas M; Friggen AH; van Meijgaarden KE; Franken KL; Ottenhoff TH; García LF; Barrera LF
    Tuberculosis (Edinb); 2012 Mar; 92(2):148-59. PubMed ID: 22226907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia.
    Arroyo L; Marín D; Franken KLMC; Ottenhoff THM; Barrera LF
    BMC Infect Dis; 2018 Jan; 18(1):26. PubMed ID: 29310595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of the T cell response to Mycobacterium tuberculosis DosR and Rpf antigens in a Colombian population of household contacts of recently diagnosed pulmonary tuberculosis patients.
    Arroyo L; Rojas M; Ortíz BL; Franken KL; García LF; Ottenhoff TH; Barrera LF
    Tuberculosis (Edinb); 2016 Mar; 97():97-107. PubMed ID: 26980501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double- and monofunctional CD4⁺ and CD8⁺ T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in long-term latently infected individuals.
    Commandeur S; Lin MY; van Meijgaarden KE; Friggen AH; Franken KL; Drijfhout JW; Korsvold GE; Oftung F; Geluk A; Ottenhoff TH
    Eur J Immunol; 2011 Oct; 41(10):2925-36. PubMed ID: 21728172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-Mediated Immune Responses to
    Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
    Front Immunol; 2020; 11():103. PubMed ID: 32117257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of late stage specific peptide antigens of Mycobacterium tuberculosis.
    Singh M; Bhatt P; Sharma M; Varma-Basil M; Chaudhry A; Sharma S
    Infect Genet Evol; 2019 Oct; 74():103930. PubMed ID: 31228643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rv2204c, Rv0753c and Rv0009 antigens specific T cell responses in latent and active TB - a flow cytometry-based analysis.
    Pathakumari B; Devasundaram S; Maddineni P; Raja A
    Int J Med Microbiol; 2018 Mar; 308(2):297-305. PubMed ID: 29325881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-γ responses to Mycobacterium tuberculosis Rpf proteins in contact investigation.
    Huang W; Qi Y; Ren C; Wen H; Franken KL; Ottenhoff TH; Shen J
    Tuberculosis (Edinb); 2013 Nov; 93(6):612-7. PubMed ID: 24053975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of CD4 and CD8 T cells producing IFN-γ in human latent and active tuberculosis.
    Rueda CM; Marín ND; García LF; Rojas M
    Tuberculosis (Edinb); 2010 Nov; 90(6):346-53. PubMed ID: 20933471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenic potential of latency associated antigens against Mycobacterium tuberculosis.
    Singh S; Saraav I; Sharma S
    Vaccine; 2014 Feb; 32(6):712-6. PubMed ID: 24300592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DosR proteins of Mycobacterium tuberculosis upregulate effector T cells and down regulate T regulatory cells in TB patients and their healthy contacts.
    Pandey K; Singh S; Bhatt P; Medha ; Sharma M; Chaudhry A; Sharma S
    Microb Pathog; 2019 Jan; 126():399-406. PubMed ID: 30476579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of dormancy-related antigens in individuals infected with Mycobacterium tuberculosis in Japan.
    Hozumi H; Tsujimura K; Yamamura Y; Seto S; Uchijima M; Nagata T; Miwa S; Hayakawa H; Fujisawa T; Hashimoto D; Inui N; Suda T; Chida K; Koide Y
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):818-24. PubMed ID: 23676169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of CD27 and CCR4 Markers on Specific CD4
    Latorre I; Fernández-Sanmartín MA; Muriel-Moreno B; Villar-Hernández R; Vila S; Souza-Galvão ML; Stojanovic Z; Jiménez-Fuentes MÁ; Centeno C; Ruiz-Manzano J; Millet JP; Molina-Pinargote I; González-Díaz YD; Lacoma A; Luque-Chacón L; Sabriá J; Prat C; Domínguez J
    Front Immunol; 2018; 9():3094. PubMed ID: 30687314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequencies of region of difference 1 antigen-specific but not purified protein derivative-specific gamma interferon-secreting T cells correlate with the presence of tuberculosis disease but do not distinguish recent from remote latent infections.
    Hinks TS; Dosanjh DP; Innes JA; Pasvol G; Hackforth S; Varia H; Millington KA; Liu XQ; Bakir M; Soysal A; Davidson RN; Gunatheesan R; Lalvani A
    Infect Immun; 2009 Dec; 77(12):5486-95. PubMed ID: 19752037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD137 is a Useful Marker for Identifying CD4
    Yan ZH; Zheng XF; Yi L; Wang J; Wang XJ; Wei PJ; Jia HY; Zhou LJ; Zhao YL; Zhang HT
    Scand J Immunol; 2017 May; 85(5):372-380. PubMed ID: 28218958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cytokine profiles related to
    Yasuda I; Saludar NRD; Sayo AR; Suzuki S; Yokoyama A; Ozeki Y; Kobayashi H; Nishiyama A; Matsumoto S; Cox SE; Tanaka T; Yamashita Y
    Front Immunol; 2024; 15():1330796. PubMed ID: 38665909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of profile and functionality of memory T cells in pulmonary tuberculosis.
    Tonaco MM; Moreira JD; Nunes FFC; Loures CMG; Souza LR; Martins JM; Silva HR; Porto AHR; Toledo VPCP; Miranda SS; Guimarães TMPD
    Immunol Lett; 2017 Dec; 192():52-60. PubMed ID: 29106984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis.
    Coppola M; van den Eeden SJ; Wilson L; Franken KL; Ottenhoff TH; Geluk A
    Clin Vaccine Immunol; 2015 Sep; 22(9):1060-9. PubMed ID: 26202436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells.
    Lindenstrøm T; Agger EM; Korsholm KS; Darrah PA; Aagaard C; Seder RA; Rosenkrands I; Andersen P
    J Immunol; 2009 Jun; 182(12):8047-55. PubMed ID: 19494330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.